These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 30202998)

  • 41. Efficacy and Safety of Coenzyme Q10 Supplementation in the Treatment of Polycystic Ovary Syndrome: a Systematic Review and Meta-analysis.
    Zhang T; He Q; Xiu H; Zhang Z; Liu Y; Chen Z; Hu H
    Reprod Sci; 2023 Apr; 30(4):1033-1048. PubMed ID: 35941510
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of synbiotic pomegranate juice on glycemic, sex hormone profile and anthropometric indices in PCOS: A randomized, triple blind, controlled trial.
    Esmaeilinezhad Z; Babajafari S; Sohrabi Z; Eskandari MH; Amooee S; Barati-Boldaji R
    Nutr Metab Cardiovasc Dis; 2019 Feb; 29(2):201-208. PubMed ID: 30538082
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical trial of the effects of coenzyme Q10 supplementation on glycemic control and markers of lipid profiles in diabetic hemodialysis patients.
    Fallah M; Askari G; Soleimani A; Feizi A; Asemi Z
    Int Urol Nephrol; 2018 Nov; 50(11):2073-2079. PubMed ID: 30251010
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
    Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
    Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Insulin resistance improvement by cinnamon powder in polycystic ovary syndrome: A randomized double-blind placebo controlled clinical trial.
    Hajimonfarednejad M; Nimrouzi M; Heydari M; Zarshenas MM; Raee MJ; Jahromi BN
    Phytother Res; 2018 Feb; 32(2):276-283. PubMed ID: 29250843
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effects of spinach-derived thylakoid supplementation in combination with calorie restriction on anthropometric parameters and metabolic profiles in obese women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled clinical trial.
    Tabrizi FPF; Farhangi MA; Vaezi M; Hemmati S
    Nutr J; 2020 Aug; 19(1):82. PubMed ID: 32782010
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome.
    Fenkci SM; Fenkci V; Oztekin O; Rota S; Karagenc N
    Hum Reprod; 2008 Jul; 23(7):1602-6. PubMed ID: 18378560
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome.
    Morrison SA; Goss AM; Azziz R; Raju DA; Gower BA
    Hum Reprod; 2017 Jan; 32(1):185-192. PubMed ID: 27827322
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations.
    Koo YA; Shin SY; Yoon BK; Choi D
    Gynecol Endocrinol; 2007; 23(8):461-7. PubMed ID: 17852414
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum adiponectin in women with polycystic ovarian syndrome and its relation to clinical, metabolic and endocrine parameters.
    Sieminska L; Marek B; Kos-Kudla B; Niedziolka D; Kajdaniuk D; Nowak M; Glogowska-Szelag J
    J Endocrinol Invest; 2004 Jun; 27(6):528-34. PubMed ID: 15717649
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intrinsic factors rather than vitamin D deficiency are related to insulin resistance in lean women with polycystic ovary syndrome.
    Sahin S; Eroglu M; Selcuk S; Turkgeldi L; Kozali S; Davutoglu S; Muhcu M
    Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2851-6. PubMed ID: 25339479
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bioavailable and free 25-hydroxyvitamin D and vitamin D binding protein in polycystic ovary syndrome: Relationships with obesity and insulin resistance.
    Naderpoor N; Shorakae S; Abell SK; Mousa A; Joham AE; Moran LJ; Stepto NK; Spritzer PM; Teede HJ; de Courten B
    J Steroid Biochem Mol Biol; 2018 Mar; 177():209-215. PubMed ID: 28734987
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of Chinese patent medicine Tian Gui Capsule in patients with polycystic ovary syndrome: a randomized controlled trial.
    Kuek S; Wang WJ; Gui SQ
    Zhong Xi Yi Jie He Xue Bao; 2011 Sep; 9(9):965-72. PubMed ID: 21906521
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of L-carnitine supplementation on insulin resistance, sex hormone-binding globulin and lipid profile in overweight/obese women with polycystic ovary syndrome: a randomized clinical trial.
    Sangouni AA; Pakravanfar F; Ghadiri-Anari A; Nadjarzadeh A; Fallahzadeh H; Hosseinzadeh M
    Eur J Nutr; 2022 Apr; 61(3):1199-1207. PubMed ID: 34727201
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of Two Different Doses of Vitamin D Supplementation on Metabolic Profiles of Insulin-Resistant Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Foroozanfard F; Talebi M; Samimi M; Mehrabi S; Badehnoosh B; Jamilian M; Maktabi M; Asemi Z
    Horm Metab Res; 2017 Aug; 49(8):612-617. PubMed ID: 28679142
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of vitamin D supplementation on metabolic and endocrine parameters in PCOS: a randomized-controlled trial.
    Trummer C; Schwetz V; Kollmann M; Wölfler M; Münzker J; Pieber TR; Pilz S; Heijboer AC; Obermayer-Pietsch B; Lerchbaum E
    Eur J Nutr; 2019 Aug; 58(5):2019-2028. PubMed ID: 29946756
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of a nutritional supplement containing vitamin E, selenium, vitamin c and coenzyme Q10 on serum PSA in patients with hormonally untreated carcinoma of the prostate: a randomised placebo-controlled study.
    Hoenjet KM; Dagnelie PC; Delaere KP; Wijckmans NE; Zambon JV; Oosterhof GO
    Eur Urol; 2005 Apr; 47(4):433-9; discussion 439-40. PubMed ID: 15774238
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of vitamin D replacement therapy on insulin resistance and androgen levels in women with polycystic ovary syndrome.
    Selimoglu H; Duran C; Kiyici S; Ersoy C; Guclu M; Ozkaya G; Tuncel E; Erturk E; Imamoglu S
    J Endocrinol Invest; 2010 Apr; 33(4):234-8. PubMed ID: 19820295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.